References
- UrsoCCaimiGOxidative stress and endothelial dysfunctionMinerva Med201110215977 Italian21317849
- Van AsscheTHendrickxJCrauwelsHMTranscription profiles of aortic smooth muscle cells from atherosclerosis-prone and - resistant regions in young apolipoprotein E-deficient mice before plaque developmentJ Vasc Res2011481314220606469
- FilipovicNRosicMTanaskovicIParodiOFotiadisDComputer simulation and experimental analysis of LDL transport in the arteriesConf Proc IEEE Eng Med Biol Soc2011201119519822254283
- YangHZhangLXiongXLiuYSpecific adhesion and accumulation of VCAM-1-targeted ultrasound microbubbles to inflammatory endothelial cells under hemodynamic shear flow simulationJ Control Release2011152Suppl 1e227e22922195873
- ZhangXLiuXShangHXuYQianMMonocyte chemoattractant protein-1 induces endothelial cell apoptosis in vitro through a p53-dependent mitochondrial pathwayActa Biochim Biophys Sin (Shanghai)2011431078779521859809
- XiaoNYinMZhangLTumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null miceMol Genet Metab200996423924419157944
- RazavianMTavakoliSZhangJSAtherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activationJ Nucl Med201152111795180221969358
- StaryHCChandlerABDinsmoreREA definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart AssociationArterioscler Thromb Vasc Biol1995159151215317670967
- KimDLeeDJangYLFacial amphipathic deoxycholic acid- modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cellsEur J Pharm Biopharm2012811142322311297
- KanekoHAnzaiTHoriuchiKTumor necrosis factor-alpha converting enzyme is a key mediator of abdominal aortic aneurysm developmentAtherosclerosis2011218247047821722904
- KuzuyaMNakamuraKSasakiTChengXWItoharaSIguchiAEffect of MMP-2 deficiency on atherosclerotic lesion formation in ApoE-deficient miceArterioscl Thromb Vasc Biol20062651120112516556856
- JohnsonJLGeorgeSJNewbyACJacksonCLDivergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteriesProc Natl Acad Sci U S A200510243155751558016221765
- ThomasACNewbyACEffect of matrix metalloproteinase-9 knockout on vein graft remodelling in miceJ Vasc Res201047429930820016204
- LaxtonRCHuYDucheneJA role of matrix metalloproteinase-8 in atherosclerosisCirc Res2009105992192919745165
- LiuDGeSZhouGMontelukast inhibits matrix metalloproteinases expression in atherosclerotic rabbitsCardiovasc Drugs Ther200923643143719998057
- GuoHShiYLiuLSunAXuFChiJRosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient miceArch Med Res200940534535119766896
- ChuangSYYangSHChenTYPangJHCilostazol inhibits matrix invasion and modulates the gene expressions of MMP-9 and TIMP-1 in PMA-differentiated THP-1 cellsEur J Pharmacol20116702–341942621925496
- HeoSHChoCHKimHOPlaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9J Clin Neurol201172697621779294
- LehrkeMGreifMBroedlUCMMP-1 serum levels predict coronary atherosclerosis in humansCardiovasc Diabetol200985019751510
- OrbeJBarrenetxeJRodriguezJAMatrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanismCirculation2011124252909291922104553
- BiniAWuDSchnuerJKudrykBJCharacterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragmentsBiochemistry19993842139281393610529239
- HillerOLichteAOberpichlerAKocourekATschescheHMatrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XIIJ Biol Chem200027542330083301310930399
- OrbeJRodríguezJACalvayracOMatrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generationArterioscler Thromb Vasc Biol200929122109211619762781
- LorenteLMartínMMLabartaLMatrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsisCrit Care2009135R15819799791
- OrbeJMonteroIRodríguezJABeloquiORoncalCPáramoJAIndependent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosisJ Thromb Haemost200751919717059420
- QuillardTTesmenitskyYCroceKSelective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosisArterioscler Thromb Vasc Biol201131112464247221903941
- WågsäterDZhuCYBjörkegrenJSkogsbergJErikssonPMMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the LdlrApob100/100 mouseInt J Mol Med201128224725321567073
- LemaîtreVDaboAJD’ArmientoJCigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signalingToxicol Sci2011123254254921742783
- EeftingDSeghersLGrimbergenJMA novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft diseaseCardiovasc Res201088236737520562095
- EeftingDde VriesMRGrimbergenJMKarperJCvan BockelJHQuaxPHIn vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1. ATF), a cell-surface directed matrix metalloproteinase inhibitorJ Vasc Surg201051242943720036101
- BasuPSenUTyagiNTyagiSCBlood flow interplays with elastin: collagen and MMP:TIMP ratios to maintain healthy vascular structure and functionVasc Health Risk Manag2010621522820407629
- JohnsonJLDwivediASomervilleMGeorgeSJNewbyACMatrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in miceArterioscler Thromb Vasc Biol2011319e35e4421719762
- BenchTJJeremiasABrownDLMatrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery diseasePharmacol Res201164656156621624471
- GaubatzJWBallantyneCMWassermanBAAssociation of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI StudyArterioscler Thromb Vasc Biol20103051034104220167662
- JefferisBJWhincupPWelshPProspective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and womenAtherosclerosis2010208255756319748093
- WangLMaYTXieXInteraction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur populationClin Appl Thromb Hemost2012181727821733941
- HuXFJinXPHuPYAssociation of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese populationClin Chem Lab Med201149101735174121722074
- Jguirim-SouissiIJelassiASlimaniAMatrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery diseaseCoron Artery Dis201122638839321606841
- DjurićT1StankovićAKončarIAssociation of MMP-8 promoter gene polymorphisms with carotid atherosclerosis: preliminary studyAtherosclerosis2011219267367821906737
- DjurićTZivkovićMStankovićAPlasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosisJ Clin Lab Anal201024424625120626027
- GhaderianSMNajarRAPanahASGenetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarctionCoron Artery Dis201021633033520616708
- MoshalKSSenUTyagiNRegulation of homocysteine-induced MMP-9 by ERK1/2 pathwayAm J Physiol Cell Physiol20062903C883C89116251475
- BescondAAugierTChareyreCGarçonDHornebeckWCharpiotPInfluence of homocysteine on matrix metalloproteinase-2: activation and activityBiochem Biophys Res Commun1999263249850310491321
- MillerAMujumdarVPalmerLBowerJDTyagiSCReversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive ratsAm J Hypertens2002152 Pt 115716311863251
- LiuFZhangJYuSEffect of folate on neointima formation and matrix metalloproteinase-9 expression after balloon injury in hyperhomocysteinemic rabbitsInt J Cardiol20081311596518180053
- OvechkinAVTyagiNSenU3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic miceAm J Physiol Lung Cell Mol Physiol20062915L905L91116815886
- SenUTyagiNKumarMMoshalKSRodriguezWETyagiSCCystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cellsAm J Physiol Cell Physiol20072936C1779C178717855772
- RybalkinSDYanCBornfeldtKEBeavoJACyclic GMP phosphodiesterases and regulation of smooth muscle functionCirc Res200393428029112933699
- BreenDMDolinskyVWZhangHResveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanismAtherosclerosis2012222237538122552115
- NeeLO’ConnellSNolanSRyanMPMcMorrowTNitric oxide involvement in TNF-alpha and IL-1 beta-mediated changes in human mesangial cell MMP-9 and TIMP-1Nephron Exp Nephrol20081102e59e6618824875
- VacekTPQipshidzeNTyagiSCHydrogen sulfide and sodium nitroprusside compete to activate/deactivate MMPs in bone tissue homogenatesVasc Health Risk Manag2013911712323658491
- GuoXGUzuiHMizuguchiTUedaTChenJZLeeJDImidaprilat inhibits matrix metalloproteinase-2 activity in human cardiac fibroblasts induced by interleukin-1β via NO-dependent pathwayInt J Cardiol2008126341442018192036
- ShinCYLeeWJChoiJWDown-regulation of matrix metalloproteinase-9 expression by nitric oxide in lipopolysaccharide-stimulated rat primary astrocytesNitric Oxide200716442543217452115
- EgiKConradNEKwanJSchulzeCSchulzRWildhirtSMInhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allograftsEur J Cardiothorac Surg200426226226915296881
- ChoeTBLeeBCParkICInhibition of matrix metalloproteinase-1 and -2 expression using nitric oxide synthase inhibitors in UV-irradiated human dermal fibroblastsJ Cosmet Sci200354322923812858222
- SenUSathnurPBKunduSIncreased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemiaAm J Physiol Cell Physiol20123031C41C5122517358
- VacekTPGillespieWTyagiNVacekJCTyagiSCHydrogen sulfide protects against vascular remodeling from endothelial damageAmino Acids20103951161116920352463
- YangGLiHTangGIncreased neointimal formation in cystathionine gamma-lyase deficient mice: role of hydrogen sulfide in α5β11-integrin and matrix metalloproteinase-2 expression in smooth muscle cellsJ Mol Cell Cardiol201252367768822200376
- GivvimaniSMunjalCGargoumRHydrogen sulfide mitigates transition from compensatory hypertrophy to heart failureJ Appl Physiol201111041093110021233344
- HongfangJCongBZhaoBEffects of hydrogen sulfide on hypoxic pulmonary vascular structural remodelingLife Sci200678121299130916257422